HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benjamin Gaborit Selected Research

XAV-19

3/2021Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial.
1/2021Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.
1/2021XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benjamin Gaborit Research Topics

Disease

5COVID-19
03/2021 - 01/2021
3Pneumonia (Pneumonitis)
03/2021 - 01/2021
2Neoplasms (Cancer)
01/2022 - 12/2017
2Infections
01/2022 - 03/2021
2Endocarditis
07/2021 - 10/2019
1Enterocolitis
01/2022
1Stomatitis
01/2022
1Septic Shock (Toxic Shock Syndrome)
01/2022
1Neutropenia
01/2022
1Critical Illness (Critically Ill)
01/2022
1Healthcare-Associated Pneumonia
01/2022
1Fever of Unknown Origin
01/2022
1Urinary Tract Infections (Urinary Tract Infection)
11/2021
1Intracranial Embolism
07/2021
1Viremia
02/2021
1Hypersensitivity (Allergy)
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Body Weight (Weight, Body)
01/2021
1Nocardia Infections
11/2020
1Pleural Effusion (Pleural Effusions)
11/2020
1Brain Abscess (Abscess, Brain)
10/2020
1Cellulitis
04/2020
1Wounds and Injuries (Trauma)
01/2020
1Wound Infection (Wound Infections)
01/2020
1Endophthalmitis (Ophthalmia)
11/2019
1Bacteremia
10/2019
1Pseudarthrosis (Pseudoarthrosis)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
12/2017
1Respiratory Insufficiency (Respiratory Failure)
12/2017
1Interstitial Lung Diseases (Interstitial Lung Disease)
03/2014
1Dermatomyositis (Dermatopolymyositis)
03/2014

Drug/Important Bio-Agent (IBA)

3XAV-19IBA
03/2021 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2020
2Cefazolin (Ancef)FDA LinkGeneric
07/2021 - 10/2019
1carbapenemaseIBA
11/2021
1Penicillins (Penicillin)FDA Link
07/2021
1Methicillin (Metin)FDA Link
07/2021
1Neutralizing AntibodiesIBA
03/2021
1Proteins (Proteins, Gene)FDA Link
03/2021
1DNA (Deoxyribonucleic Acid)IBA
02/2021
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
02/2021
1Calcineurin InhibitorsIBA
02/2021
1Arsenic Trioxide (Trisenox)FDA Link
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1Abatacept (Orencia)FDA Link
11/2020
1RNA (Ribonucleic Acid)IBA
11/2020
1Streptozocin (Streptozotocin)FDA Link
01/2020
1Linezolid (Zyvox)FDA Link
11/2019
1tedizolidIBA
01/2018

Therapy/Procedure

3Therapeutics
01/2022 - 03/2014
1Induction Chemotherapy
01/2022
1Immunotherapy
03/2021
1Self Medication
04/2020
1Surgical Amputation (Amputations)
01/2020
1Organ Transplantation
12/2017
1Artificial Respiration (Mechanical Ventilation)
12/2017